Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03726203
Other study ID # 2017_81
Secondary ID 2018-A01276-49
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2019
Est. completion date April 27, 2021

Study information

Verified date April 2021
Source University Hospital, Lille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

During laparoscopy, trocars are essential: they allow the passage of instruments through the wall. In gynecology, with exception, trocars 5mm (used for the passage of endo-scissors and forceps) and 10 to 12mm are used (especially for optics). Trocars are responsible for complications, such as vascular wounds, digestive wounds, pain, infections or postoperative hernias, or aesthetic sequelae, and should be chosen with caution: most complications of laparoscopy are essentially due to their placement, and the complications at the introduction of the first trocar are the most frequent. The MiniLap® system developed by Teleflex does not require trocars in the case of a single forceps, or a single 5mm trocar with the necessary forceps change (this is the Percuvance® system). The aim of the latter is to make minimally invasive surgery even less invasive, thanks to a reduction in the number of trocars used (in many cases, elimination of two trocars), smaller incisions (percutaneous use of instruments, with a diameter of 2,4mm) thus reducing the complications


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date April 27, 2021
Est. primary completion date April 27, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - BMI <35kg / m2 - No history of multiple abdominopelvic surgery - Without absolute contraindication to laparoscopy - In the context of ambulatory surgery - With precise laparoscopy of indication: - Exploratory or diagnostic - Exploration of infertility - Performing a tubal permeability test - Performing a salpingectomy - Realization of a tubal sterilization - Realization of a tubal plasty - Performing an ovariectomy - Performing a simple ovarian cystectomy - Patient have been informed during her preoperative consultation and have signed the consent in a free and informed manner upon admission to hospital Exclusion Criteria: - Performing an emergency surgery - Carcinological surgery - Performing a benign but complex surgery such as: - Hysterectomy - Prolapse cure - promontofixation - Complex surgery of endometriosis - Removal of large cyst from the ovary. - Person unable to receive informed information and / or give consent. Person deprived of liberty. - Pregnant or nursing woman.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
laparoscopic gynecologic surgery with the MiniLap System.
Subjects participating in the study will undergo laparoscopic gynecologic surgery as planned in the routine care, but using the MiniLap System instead of the conventional single-use trocars used usually.
laparoscopic gynecologic surgery with the conventional single-use trocars.
Subjects participating in the study will undergo laparoscopic gynecologic surgery as planned in the routine care using the conventional single-use trocars used usually.

Locations

Country Name City State
France Hôpital Jeanne de Flandres, CHU Lille

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Lille Teleflex

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The time required to validate the Marshall and Chung criteria authorizing outpatient discharge when using the Minilap® system in comparison to the use of conventional trocars. at the end of surgery, an average 3 hours
Secondary Pain using the Visual Analog Scale (VAS) subjective evaluation of pain of the patient by 0 to 10 scale at immediate postoperative (baseline,1 hour and 3 hours) and postoperative visit (6 weeks ± 1 after surgery).
Secondary Aesthetic scars using a scale of 0 to 10 subjective evaluation of the patient and the surgeon by means of a 0 to 10 scale postoperative visit (6 weeks ± 1 after surgery).
Secondary number of complication per operative collection of the complications per operating by means of a questionnaire to be filled(performed) by the surgeon at the end of intervention At immediate postoperative (baseline,1 hour and 3 hours)
Secondary of the intraoperative use of the trocar system using a questionnaire to be completed by the surgeon At immediate postoperative (baseline,1 hour and 3 hours)
Secondary post-operative complications at the level of the trocar apertures using a questionnaire at immediate postoperative (baseline,1 hour and 3 hours) and postoperative visit (6 weeks ± 1 after surgery).